Washington Update: The Federal Policies Shaping Orthopaedic Practices in 2027
Join Us Virtually
Washington Update: The Federal Policies Shaping Orthopaedic Practices in 2027
December 9, 2026
Join AAOE for a timely update on the federal policy and political developments affecting orthopaedic practices. This session will review key changes in the CY 2027 Medicare Physician Fee Schedule (PFS), including changes to reimbursement, implementation of the Ambulatory Specialty Model (ASM), and finalized policies affecting Remote Therapeutic Monitoring (RTM) and Remote Patient Monitoring (RPM). The webinar will also cover anticipated year-end congressional action on Medicare physician payment and other healthcare priorities, as well as the potential implications of the 2026 elections for musculoskeletal care providers. Attendees will leave with a practical understanding of the federal issues most likely to affect reimbursement, operations, and strategic planning in 2027.
Register Now!
Learning Objectives:
- Describe key federal legislative, regulatory, and political developments that may affect orthopaedic practices in 2027.
- Identify emerging Medicare payment and delivery system policies that could influence physician reimbursement, practice operations, and care delivery.
- Assess the potential implications of congressional action, Administration priorities, and the 2026 elections for musculoskeletal providers and practice leaders.
For more information, contact info@aaoe.net.
Due to AAOE policies, AI Bots are not allowed in webinars, and AAOE staff will remove them.
Claire Ernst, JD
Director, Government Relations & Public Policy, Hooper Lundy & Bookman, P.C.
Claire focuses her practice on protecting and advancing the interests of providers and trade associations before legislators, regulators, staff, and others who craft and influence health care policies and priorities, primarily on issues relating to provider payment, including administrative burden, digital health, and Medicare Advantage. Claire’s extensive background working in-house for health care industry trade and advocacy associations helps her forge connections with leadership and membership alike, allowing her to step into their shoes and better convey their perspectives and concerns to policymakers. Before joining HLB, Claire served as Director of Government Affairs for the Medical Group Management Association (MGMA), overseeing advocacy strategy and representing the organization’s interests in front of Congress and Executive Branch agencies. In 2023, Claire’s talents and achievements earned her recognition by Modern Healthcare, which included her in its list of the Top 25 Emerging Leaders (previously Up & Comers) for her significant contributions in the area of health care policy. Claire received a J.D. from Suffolk University Law School and a B.A. from Franklin & Marshall College. You can contact Claire at cernst@hooperlundy.com.